AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| EPW | Ann: Daily share buy-back notice - Appendix 3E | 24/04/18 | 0 | 42 | |||
|
|||||||
| EPW | ERW in the news | 23/04/18 | 0 | 95 | |||
|
|||||||
| EPW | Ann: Daily share buy-back notice - Appendix 3E (Amended) | 23/04/18 | 1 | 115 | |||
|
|||||||
| EPW | Ann: Daily share buy-back notice - Appendix 3E | 23/04/18 | 0 | 60 | |||
|
|||||||
| EPW | Ann: Daily share buy-back notice - Appendix 3E | 21/04/18 | 13 | 1.6K | |||
|
|||||||
| EPW | Ann: Daily share buy-back notice - Appendix 3E | 20/04/18 | 0 | 67 | |||
|
|||||||
| EPW | Ann: Daily share buy-back notice - Appendix 3E | 19/04/18 | 0 | 52 | |||
|
|||||||
| EPW | Ann: Daily share buy-back notice - Appendix 3E | 18/04/18 | 0 | 64 | |||
|
|||||||
See All Discussions
ASX News